Nader Z. Pourhassan
Overview
Nader Z. Pourhassan received an average of $4M in total compensation, including $483K in salary, at CytoDyn from 2013 to 2022.
2022CytoDynPresident and Chief Executive Officer
2021CytoDynPresident and Chief Executive Officer
2020CytoDynPresident and Chief Executive Officer
2019CytoDynPresident and Chief Executive Officer
2017CytoDynPresident and Chief Executive Officer
2016CytoDynPresident and Chief Executive Officer
2015CytoDynPresident and Chief Executive Officer
2014CytoDynPresident and Chief Executive Officer
2013CytoDynPresident and Chief Executive Officer
Source: SEC filings on October 26, 2022, September 1, 2020, July 24, 2017, July 20, 2016, February 18, 2016, and January 22, 2015.
Related executives
We found seven more executives who work or worked at CytoDyn.
Scott Kelly
CytoDyn
Chief Medical Officer
Chris Recknor
CytoDyn
Sr. Executive VP of Clinical Operations
Antonio Migliarese
CytoDyn
Chief Financial Officer
Nitya Ray
CytoDyn
Chief Technology Officer
Craig Eastwood
CytoDyn
Chief Financial Officer
Michael Mulholland
CytoDyn
Chief Financial Officer
Anthony Caracciolo
CytoDyn